ORTHOPEDIATRICS CORP Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Orthopediatrics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q3 2024.
  • Orthopediatrics Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.92M, a 72.5% decline year-over-year.
  • Orthopediatrics Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$28.4M, a 28.5% decline year-over-year.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$21M, a 1767% decline from 2022.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2022 was $1.26M.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$16.3M, a 50.6% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28.4M -$7.92M -$3.33M -72.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$25.1M -$6.03M -$3.14M -109% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$22M -$7.81M -$999K -14.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$21M -$6.69M +$1.16M +14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$22.1M -$4.59M -$23.1M -125% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $999K -$2.89M -$2.55M -767% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 $3.55M -$6.81M +$2.29M +25.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 $1.26M -$7.85M -$7.92M -11000% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $9.18M $18.5M +$20.7M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$11.6M -$333K +$3.42M +91.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$15M -$9.1M +$1.28M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$16.3M $72K +$14.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 -$30.3M -$2.2M +$2.34M +51.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$32.7M -$3.76M +$5.69M +60.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-01
Q1 2021 -$38.4M -$10.4M -$5.43M -110% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-01
Q4 2020 -$32.9M -$14M -$8.58M -158% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$24.4M -$4.54M -$1.88M -70.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22.5M -$9.45M -$6.83M -261% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$15.7M -$4.95M -$1.93M -63.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$13.7M -$5.43M -$2.96M -120% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$10.8M -$2.66M -$799K -42.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$9.97M -$2.62M +$74K +2.75% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$10M -$3.02M +$1.98M +39.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$12M -$2.47M +$2.38M +49.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$14.4M -$1.87M -$329K -21.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$14.1M -$2.69M -$1.43M -113% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$12.6M -$5M -$3.72M -289% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$8.93M -$4.85M -$1.21M -33.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$7.72M -$1.54M -$690K -81.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$7.03M -$1.27M -$978K -340% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$6.05M -$1.29M +$520K +28.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$6.57M -$3.63M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$846K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$288K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$1.81M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.